Placenta-derived nasal spray shows promise against Alzheimer's in mice
Italian researchers report that extracellular vesicles from placental cells reduce neuroinflammation and preserve memory in transgenic mice.
What to know
- Italian researchers developed a nasal spray containing extracellular vesicles from human placental cells that improved cognitive performance in Alzheimer's disease transgenic mice over six months of treatment.
- The spray reduced amyloid-beta deposits and neuroinflammation in the hippocampus while boosting neuroplasticity-related proteins, without affecting tau phosphorylation.
- The same vesicles reduced neuronal deterioration when tested on human neurons derived from Alzheimer's disease patients, suggesting translational potential.
“A particularly promising avenue within regenerative medicine involves harnessing the therapeutic potential of extracellular vesicles, particularly those isolated from mesenchymal stromal cells (MSCs).”
Research team, Study authors · ScienceAlert ↗
Andrea Papait Lead author, cell biologistCatholic University of the Sacred Heart Research institution
How it unfolded 2 developments, newest first · click a bar or a number to jump articlesposts
-
2
Full study details emerge: spray reduced amyloid-beta and neuroinflammation
ScienceAlert published comprehensive coverage showing the nasal spray significantly reduced amyloid-beta deposits in the hippocampus and lowered neuroinflammation by reducing activation of astrocytes and microglia. Behavioral tests confirmed improved object recognition and spatial memory in treated mice, while separate experiments on human Alzheimer's patient-derived neurons showed the EV treatment reduced neuronal deterioration.
“MSC-derived EVs (MSC-EVs) are nanoparticles that mediate intercellular communication and have been demonstrated to potentially deliver bioactive molecules with anti-inflammatory and neuroprotective properties.”
— Andrea Papait, lead author - 1 day quiet
-
1
Study shows placenta-derived nasal spray protects neurons in Alzheimer's mouse model
Researchers from Catholic University of the Sacred Heart in Italy published findings that a nasal spray containing human amniotic mesenchymal stromal cell-derived vesicles (hAMSC-EVs) improved cognitive performance in transgenic mice engineered to develop Alzheimer's disease when administered twice weekly for six months.
-
first by Technology Networks, 8d ago · also Drug Target Review, ScienceAlert, Eurasia Review
4 more headlines
- Nasal spray protects neurons and memory in Alzheimer's mouse model medicalxpress.com · 8d ago
- Nasal spray delivers amniotic vesicles to combat Alzheimer’s disease Drug Target Review · 8d ago
- Nasal Spray Derived From Human Placenta Protects Against Alzheimer's Decline, Study in Mice Shows ScienceAlert · 8d ago
- Alzheimer’s: A Nasal Spray Protects Neurons And Memory Eurasia Review · 5d ago
-